Graham Corporation Quarterly Results: Revenue Climbs While Profitability Steps Down

Bottom line

For the three-month reporting period covered by GRAHAM CORP's 10-Q covering period-ended-2026-06-30 (filed under accession 0001193125-26-336752, ticker GHM, CIK 0000716314), the company stayed profitable on a reported basis but the bottom line moved lower relative to the prior-year comparative quarter, while the top line moved higher.

On revenue, $71,342,000 for the three months ended June 30, 2026 was higher than the prior-year figure $55,487,000 recorded for the three months ended June 30, 2025, on a directionally authorized year-over-year increase with both quarters in positive territory. On profitability, both operating income and net income stepped down: $4,152,000 for the three months ended June 30, 2026 was lower than $4,964,000 for the three months ended June 30, 2025 (directionally authorized decrease; current period remained profitable, prior-year comparative also profitable, with a profit-to-profit transition). Net income tracked the same pattern, with $3,912,000 for the three months ended June 30, 2026 lower than $4,595,000 for the three months ended June 30, 2025 (directionally authorized decrease; current and prior both positive, profit-to-profit transition). Diluted earnings per share followed suit: $0.33 per diluted share for the three months ended June 30, 2026 was lower than $0.42 per diluted share for the three months ended June 30, 2025, again with a directionally authorized decrease, both periods positive (profit), and a profit-to-profit transition.

The filing includes a basis-of-presentation note and a business-combination note describing the FlackTek acquisition added to the consolidated subsidiaries earlier in the fiscal year. The acquisition note describes how the preliminary purchase price was allocated across tangible assets, customer relationships, technology and technical know-how, tradename, and goodwill, and explains the amortization conventions applied to those intangibles. The condensed consolidated financial statements themselves are described as having been prepared in accordance with U.S. GAAP, with the company noting that they do not include all information required for complete financial statements and referring readers to the most recent Annual Report on Form for additional context. Management also cautions that interim results are not necessarily indicative of results for the full fiscal year.

The filing evidence does not attribute this change to any single cause.

None beyond the directional relationships stated above; the filing evidence does not present figures that contradict the authorized directions.

UNKNOWN: The filing evidence contains no peer or industry comparison. The filing evidence does not disclose segment-level detail for this dimension.

Financial performance

- Across the headline lines the three-month picture is mixed: top-line revenue expanded year over year, while profitability lines contracted, producing a wider spread between the income statement's two ends than in the prior-year quarter. - Revenue from Contract with Customer, Excluding Assessed Tax moved higher in the current period versus the prior-year comparative, a direction the filing's authorized comparisons confirm and that the company itself frames around a larger, more diversified order book following the FlackTek acquisition described in the cited note on acquisitions.

- Net Income (Loss) Attributable to Parent, however, was lower year over year, and Operating Income (Loss) likewise moved lower. Both lines remain in profit territory versus the prior-year quarter, so the transition is profit-to-profit on a smaller base rather than a swing into loss. - Earnings Per Share, Diluted tracked the same pattern, registering a decrease against the prior-year comparative while staying positive on a per-share basis.

The diluted EPS, net income, and operating income moves are internally consistent: lower operating profit flowing to lower bottom-line profit and a proportionally similar per-share outcome. - No quarter-over-quarter comparison is presented in the filing evidence: the catalog carries the three-month result versus the prior-year three-month comparative and does not include a sequential prior-quarter figure, so the QoQ dimension for this period is not in the filing's evidence set. - The company did not publish formal numerical guidance for the upcoming quarter or full year in this filing.

Management's forward-looking color is qualitative, pointing to the broadened product portfolio and installed footprint from the FlackTek transaction and to multi-year performance-based earn-out targets tied to progressively higher adjusted EBITDA thresholds, but the filing does not translate those into specific revenue, margin, or EPS guidance figures. - On accounting context, the cited note on acquisitions explains that the FlackTek transaction was accounted for as a business combination with assets and liabilities recognized at fair value as of the acquisition date, that goodwill was recorded for the excess over fair value, and that the cash consideration was funded through borrowings on the Company's line of credit.

The cited note also clarifies that customer relationships and technology and technical know-how are amortized on a straight-line basis over multi-year useful lives, with customer relationships in selling, general and administrative expense and technology in cost of products sold, while tradename is treated as an indefinite-lived intangible. - Revenue recognition policy in the filing distinguishes point-of-shipment contracts from over-time contracts, with over-time recognition tied to assets that have no alternative use and an enforceable right to payment for performance completed to date, and transaction price allocated across distinct performance obligations based on estimated relative standalone selling prices.

- Baseline context against peers is not available from this filing: there is no peer or industry comparison in the filing evidence, and segment-level detail for revenue or operating income is not disclosed at the line-item level captured here. For readers translating these year-over-year moves into their own return-on-capital framing, the ROI Calculator sits alongside this analysis as a reference point rather than a substitute for the filing's own disclosures.

Operating drivers and segments

The filing evidence does not disclose segment-level detail for this dimension. Revenue for GRAHAM CORP during the three months ended June 30, 2026 is reported at $71,342,000 USD, higher than the prior-year comparative of $55,487,000 USD for the three months ended June 30, 2025. Operating income for the three months ended June 30, 2026 is reported at $4,152,000 USD, lower than the prior-year comparative of $4,964,000 USD for the three months ended June 30, 2025. The pattern shows top-line growth combined with a contraction at the operating-profit level on a year-over-year basis. The filing presents the company on a consolidated basis, with the acquired FlackTek operations (acquired earlier and described in the cited note) now folded into the reporting structure. The filing evidence does not disclose segment-level detail for this dimension.

Management attributes the period's character to the FlackTek acquisition, describing FlackTek as a provider of advanced mixing and material processing solutions serving OEMs, research and development centers, defense laboratories, and industrial manufacturers across multiple end markets including adhesives, sealants, functional coatings, composites, electronics, energetics, oil & gas, food, battery, aerospace and space, medical, and other industrial applications. The purchase price allocation identifies intangibles for customer relationships (amortized over twelve years), technology and technical know-how (amortized over nine years), and a tradename treated as an indefinite-lived intangible. Management characterizes FlackTek's mixing systems as process-critical and market-agnostic. The filing evidence does not attribute this change to any single cause.

Cash flow and capital

- Reported facts - Cash and Cash Equivalents, at Carrying Value stood at $26,953,000 USD as of the balance sheet date of June 30, 2026, with Long-term Debt, Excluding Current Maturities recorded at $0 USD on the same balance-sheet date, leaving the company in a net-cash position rather than a levered one. - Trade working-capital balances as of the balance sheet date of June 30, 2026 were $49,750,000 USD for Accounts Receivable, after Allowance for Credit Loss, and $24,697,000 USD for Accounts Payable, Current. - For the three months ended the three months ended June 30, 2026, the statement of cash flows showed Net Cash Provided by (Used in) Operating Activities of -$12,650,000 USD, Net Cash Provided by (Used in) Investing Activities of -$1,042,000 USD, and Net Cash Provided by (Used in) Financing Activities of $34,044,000 USD.

Capital spending, captured as Payments to Acquire Property, Plant, and Equipment, totalled $2,609,000 USD for the same window. - The prior-year comparative for the three months ended the three months ended June 30, 2025 recorded Net Cash Provided by (Used in) Operating Activities of -$2,259,000 USD, Net Cash Provided by (Used in) Investing Activities of -$7,004,000 USD, Net Cash Provided by (Used in) Financing Activities of -$1,614,000 USD, and Payments to Acquire Property, Plant, and Equipment of $7,004,000 USD. - Management explanations - The cited note on stockholders' equity (captured under Note 10 and Note 2) discloses that the company utilized a portion of the proceeds for debt repayment and intends to apply the remaining proceeds toward future investment in organic and inorganic growth opportunities, framing capital deployment around balance-sheet repair alongside growth funding.

- The revenue-recognition footnote (referenced within Item 1 through Item 6 of Part II) explains the timing link between invoicing, customer deposits and trade accounts receivable on the Condensed Consolidated Balance Sheets, which contextualises the working-capital figures reported above without altering their reported amounts. - Analyst inference - Operating cash flow moved in the authorized direction from the prior-year three-month comparative: both windows show a use of cash, with the current quarter's outflow greater than the prior-year figure.

The filing evidence does not attribute this change to any single cause. - Investing cash flow stayed negative in both periods, with the current-quarter use of cash higher than the prior-year comparative, consistent with elevated Payments to Acquire Property, Plant, and Equipment relative to the prior year. The filing evidence does not attribute this change to any single cause.

- Financing cash flow swung from a use of cash in the prior-year three-month comparative to a source of cash in the current quarter, the only one of the three cash-flow categories to change sign year over year. The filing evidence does not attribute this change to any single cause. - Capital expenditures were lower in the three months ended June 30, 2026 than in the three months ended June 30, 2025, even though the investing-activities line deteriorated, suggesting other investing outflows beyond property, plant and equipment added to the cash drag this quarter.

The filing evidence does not attribute this change to any single cause. - With cash on hand exceeding long-term debt and the equity-proceeds language pointing to debt repayment plus growth investment, the balance sheet as of the balance sheet date of June 30, 2026 supports continued organic capex and selective inorganic optionality without near-term refinancing pressure. - Counter-evidence - The decline in operating cash flow alongside still-elevated capex is the principal counterweight to the net-cash balance-sheet story: even with a low-debt capital structure, the current quarter's three cash-flow lines collectively point to a deeper cash draw than a year earlier.

The filing evidence does not attribute this change to any single cause. - Unknowns - The filing does not break out segment-level cash generation or working-capital detail, so any attribution to individual end-markets is unavailable. The filing evidence does not disclose segment-level detail for this dimension.

- The filing does not include peer or industry cash-flow benchmarks for the same window. The filing evidence contains no peer or industry comparison. - The filing does not quantify free cash flow or disclose dividend activity, share repurchases, or lease repayments in this section's catalog, leaving the full capital-return picture incomplete on the evidence supplied.

Peer and historical context

- Against the prior-year quarter, the top line moved in opposite direction to the bottom line, a split pattern that the filing itself does not narrate. - Working capital absorbed more cash this year than last, even though reported earnings were still positive in both windows, suggesting that accruals, receivables, or inventory swings were the swing factor inside the cash figure rather than earnings quality itself.

- Both reported quarters remained profitable, so the deterioration in earnings and in operating cash is not a transition into a loss; the company stayed in positive territory across all four earnings dimensions on a year-over-year basis. - The current-period operating cash figure is still a use of cash, mirroring the prior-year period in direction, so the year-over-year move is one of magnitude rather than a flip in sign.

Scenario analysis

The base case for the three-month reporting period of GRAHAM CORP (GHM), filed under 10-Q for period-ended-2026-06-30 at 0001193125-26-336752, blends the two reported facts that the filing actually anchors. Revenue from Contract with Customer, Excluding Assessed Tax rose year over year, lifting from $55,487,000 USD in the three months ended June 30, 2025 to $71,342,000 USD in the three months ended June 30, 2026 — a directionally higher top line. Net Income (Loss) Attributable to Parent moved the opposite way, easing from $4,595,000 USD in the three months ended June 30, 2025 to $3,912,000 USD in the three months ended June 30, 2026, still a profit on both sides of the comparison. With revenue climbing and earnings softening, the base case reads as a margin-compression quarter: the company is selling more but keeping less of each incremental dollar.

The upside case layers in the disclosures that point toward recovery. Management describes proceeds that have been partly applied to debt repayment, with the balance earmarked to help fund future investment in organic and inorganic growth opportunities. Cash deployment of that type is consistent with a balance-sheet clean-up now that produces cleaner future earnings, although the filing does not tie those proceeds to any particular P&L line, so the link is qualitative only. On the operations side, the remaining unsatisfied performance obligations measure continues to frame the order book that will convert into future revenue, and revenue is recognized either over time or upon shipment, which means a backlog of long-cycle contracts can still flow into later quarters. The base case implicitly assumes the authorized quarter-over-quarter revenue increase holds; the upside pushes further by assuming that recent investments begin to flow through, supporting an earnings rebound.

The downside case reads the same pair of facts through the legal and governance overlays in the filing. The company is a co-defendant with numerous other defendants in pending lawsuits and intends to vigorously defend itself against the claims. Management believes resolution will not have a material adverse effect, but the same disclosure concedes that legal matters are subject to inherent uncertainties and that the ultimate resolution of the asbestos-related lawsuits could have a material adverse impact on the company's financial position and the results of operations. Layered on top of the already-softening earnings trend, an adverse legal outcome is the cleanest scenario lever the filing surfaces. Governance adds a second risk channel: a prior whistleblower investigation at the wholly-owned subsidiary GIPL identified evidence supporting the complaint and other misconduct by employees; all involved employees have been terminated or are no longer with the company, and remedial actions have been implemented, including strengthening its compliance program and internal controls. The downside case assumes that remediation costs, or any further legacy misconduct surfaces, compress margins further while the authorized revenue increase only partly offsets the impact. The filing evidence does not attribute this change to any single cause.

Risks and what to watch

- Reported facts: Revenue from Contract with Customer, Excluding Assessed Tax for the three months ended June 30, 2026 was $71,342,000 USD, higher than the prior-year comparative of $55,487,000 USD for the three months ended June 30, 2025. Net Income (Loss) Attributable to Parent for the three months ended June 30, 2026 was $3,912,000 USD, lower than the prior-year comparative of $4,595,000 USD for the three months ended June 30, 2025, with both windows remaining profitable on a reported basis. - Management explanations: Management discloses in Item 1A that it is a co-defendant with numerous other defendants in asbestos-related lawsuits and intends to vigorously defend itself, while characterizing prior similar suits as either dismissed when it was shown the Company had not supplied products to the plaintiffs' places of work or settled for immaterial amounts.

Management further cautions that legal matters carry inherent uncertainties and that the ultimate resolution of these asbestos-related lawsuits could have a material adverse impact on the Company's financial position and results of operations. Separately, management describes the whistleblower investigation at its wholly-owned subsidiary Graham India Private Limited as concluded during the third quarter of a prior fiscal year, with the other misconduct described as isolated to a few employees, not deemed material, and spanning a multi-year period.

Involved employees have been terminated or are no longer with the Company, the statutory auditor and bookkeeper of GIPL tendered their resignations and were replaced, remedial actions including a strengthened compliance program and internal controls were implemented, and the findings were voluntarily reported to the appropriate authorities in India. - Analyst inference: The juxtaposition of higher top-line revenue and lower bottom-line net income points to cost, mix, or expense dynamics diverging from the prior-year quarter.

The filing evidence does not attribute this change to any single cause. - Counter-evidence: Management's own framing partially offsets the asbestos concern by characterizing prior outcomes as immaterial and by emphasizing vigorous defense, and the India subsidiary matter is described as isolated, not deemed material, with remediation already underway and authorities voluntarily informed. Together these soften, though do not eliminate, the litigation and compliance overhangs flagged in Item 1A.

, so readers cannot isolate which product line, geography, or contract contributed to the gap. , so relative performance versus competitors or the defense and industrial end markets remains unstated. The ultimate financial impact of pending asbestos matters is described only qualitatively as not currently expected to be material, with no quantification.

- Metrics to watch next period: readers should monitor whether the year-over-year revenue gain continues while the net income margin compresses further, whether operating cash flow turns back toward positive territory from the negative result disclosed elsewhere in the filing, and whether any new disclosure emerges in Item 1A regarding the asbestos litigation backlog or the India subsidiary remediation. Capital allocation activity covered in Note 10 and Note 2 is also worth tracking, alongside the controls and procedures discussion in Item 4, since those speak directly to the internal-control strengthening that management cites.

For readers modeling returns on capital decisions tied to those equity movements, the ROI Calculator can help frame the math against the litigation overhang.